Watchman Laa denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for watchman laa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Applies Step Therapy to Watchman LAA — and How to Appeal

The Watchman Left Atrial Appendage closure device is used in patients with non-valvular atrial fibrillation as a non-pharmacologic alternative to lifelong anticoagulation. Cigna's step-therapy protocol for this device typically requires documented failure of, or intolerance to, guideline-recommended oral anticoagulation before the device will be covered. A step-therapy denial means Cigna's records do not reflect adequate prior anticoagulant trials — even when the patient has genuinely tried and failed them. This mismatch between clinical reality and administrative records is common and fully correctable on appeal.

## Why This Denial Is Appealable

Step-therapy denials are clinical coverage decisions subject to full appeal rights. Under ACA Section 2719, non-grandfathered plan members may pursue independent external review. Under ERISA Section 503, employer-plan members are entitled to a full-and-fair review with a complete written explanation of the clinical rationale. The external-review request window is generally 180 days from denial, with an expedited 72-hour pathway available when delay would seriously jeopardize life or health. Many states have also enacted step-therapy override laws that require insurers to grant exceptions when a patient has already tried and failed required treatments — check your state's rules.

## Concrete Appeal Steps

1. Request the denial letter and identify exactly which prior-treatment steps Cigna says have not been satisfied. 2. Obtain Cigna's published medical coverage policy for the Watchman device and note the precise anticoagulation step-therapy requirements. 3. File the internal appeal within the plan's deadline, submitting documentation (see below) that proves each required step has been satisfied or that a step-therapy exception applies. 4. Escalate to external review if the internal appeal is denied.

## Documentation to Gather

• Diagnosis confirmation: Atrial fibrillation diagnosis with rhythm documentation and stroke-risk assessment per the treating cardiologist's chart.
• Prior-treatment history: A detailed chronological record of every anticoagulant tried, including dates started and stopped, and the documented clinical reason for discontinuation (e.g., major bleeding event with hospitalization records, allergy documented in the chart, or documented patient-specific contraindication as stated by the prescribing physician — not just a preference).
• Clinical severity: Bleeding history, prior hemorrhagic events, fall-risk assessment, or comorbidities that the treating physician has documented as making long-term anticoagulation unsuitable.
• Prescriber medical-necessity letter: A signed letter from the implanting electrophysiologist or cardiologist stating that the patient meets the step-therapy exception criteria under the plan and FDA labeling, and explaining why proceeding to the Watchman device is medically appropriate without additional anticoagulant trials.
• Applicable cardiology society guideline reference: The prescriber may reference the relevant ACC/AHA or HRS guideline organization's recommendation for this device category without needing to quote specific statistics.

## Criteria-Mapping Structure

Build a two-column table listing each step-therapy requirement from Cigna's policy in the left column. In the right column, provide the specific chart note date, lab result, or event record that fulfills that requirement. A direct step-by-step match eliminates ambiguity and makes it difficult for a reviewer to sustain the denial without engaging with each documented fact.